Mirtilene forte Capsules 177 mg, # 20

Myrtilene forte caps.

177mg No. 20

Name ENG

MIRTILENE FORTE

Clinical and pharmacological group

A drug that improves the functional state of the retina for systemic use in ophthalmology

ATX code

Other drugs for the treatment of eye diseases

Dosage

177mg

Structure

Capsules are soft gelatinous, oval, dark brown in color with a slightly shiny smooth surface.

Indications

The use of capsules is recommended for:

myopia of varying degrees

acquired hemeralopia

diabetic retinopathy

violations of the mechanisms of adaptation of the organs of vision to darkness, for example, night and twilight vision

muscle asthenopia

central atherosclerotic retinal degeneration

tapetoretinal retinal abiotrophy.

Contraindications

The main contraindication to the prescription of the drug is individual hypersensitivity to its components.

Care should be taken when using these capsules during lactation and pregnancy, since their effect on the fetus and baby has not been fully understood.

INN / Active ingredient

Blueberry fruit extract dry

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 2.5 years

Specifications

Category

Vitamin and mineral complexes

Scope of the drug

Vitamins

Release form

Capsules

Manufacturer country

Italy

Package quantity, pcs

twenty

Scope of application

Ophthalmology

Way of introduction

Through the mouth

Mode of application

Inside.

1 capsule 3 times a day.

The course of treatment is 1 month.

Vacation conditions

Without recipe

Brand name

SIFI

The amount of the dosage form in the primary package

20 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Anatomical and therapeutic characteristics

S01XA Other preparations for the treatment of eye diseases

Dosage form

Capsules

Packaging

Box

The target audience

Adult

Expiration date in days

913

Dosage (volume) of the substance in the preparation

dry extract of blueberries 177 mg

Package weight, g

twenty

Pharmaco-therapeutic group

:

A plant-based agent for the regeneration of retinal photoreceptors